Vivek Kumbhari1, Ling Li1, Klaus Piontek1, Masaharu Ishida1, Rongdang Fu1, Bassem Khalil1, Caroline M Garrett2, Eleni Liapi3, Anthony N Kalloo1, Florin M Selaru4. 1. Department of Medicine and Division of Gastroenterology and Hepatology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA. 2. Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 3. Department of Radiology and Radiological Sciences, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA. 4. Department of Medicine and Division of Gastroenterology and Hepatology, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA; The Institute for NanoBio Technology, Johns Hopkins University, Baltimore, Maryland, USA.
Abstract
BACKGROUND AND AIMS: A simple, safe, targeted, and efficient in vivo DNA delivery system is necessary for clinical-grade liver-targeted gene therapy in humans. Intravascular hydrodynamic gene delivery has been investigated in large animal models, but translation to humans has been hampered by its technical challenges, invasiveness, and potential for significant cardiovascular adverse events. We posited that intrabiliary delivery of DNA plasmids via ERCP-guided hydrodynamic injection could overcome these obstacles. METHODS: Twelve pigs (40-50 kg) were divided into 3 groups (4 per group) and survived 21, 30, or 60 days. ERCP was performed by inflating a balloon catheter in the common hepatic duct and creating a closed space between it and the liver parenchyma. Last, a solution composed of plasmid/sleeping beauty (SB) mix was injected under pressure through the catheter into the closed space. Swine were killed at the 3 different time points and liver tissue harvested. Plasmid DNA expression and functional translated protein expression were assessed. RESULTS: ERCP-guided hydrodynamic delivery of naked plasmid DNA facilitated by pCytomegalovirus-Sleep Beauty (pCMV-SB) transposons was technically feasible and devoid of cardiovascular and local adverse events in all 12 pigs. Furthermore, plasmid DNA (both single and combination) was successfully transferred into swine hepatocytes in all 12 pigs. Additionally, stable integration of the DNA constructs in hepatocyte genomic DNA was reliably noted at all 3 time points. In the 4 swine that were kept alive to 60 days, successful genomic integration and subsequent protein expression was observed in the targeted liver tissue. CONCLUSIONS: ERCP-guided hydrodynamic delivery of gene therapy may usher in the next chapter in gene therapy with the potential to impact a variety of single-gene, complex genetic, and epigenetic liver diseases. It also raises the possibility that other nucleic acid therapeutics (microRNA, lncRNA, siRNA, shRNA) could similarly be delivered.
BACKGROUND AND AIMS: A simple, safe, targeted, and efficient in vivo DNA delivery system is necessary for clinical-grade liver-targeted gene therapy in humans. Intravascular hydrodynamic gene delivery has been investigated in large animal models, but translation to humans has been hampered by its technical challenges, invasiveness, and potential for significant cardiovascular adverse events. We posited that intrabiliary delivery of DNA plasmids via ERCP-guided hydrodynamic injection could overcome these obstacles. METHODS: Twelve pigs (40-50 kg) were divided into 3 groups (4 per group) and survived 21, 30, or 60 days. ERCP was performed by inflating a balloon catheter in the common hepatic duct and creating a closed space between it and the liver parenchyma. Last, a solution composed of plasmid/sleeping beauty (SB) mix was injected under pressure through the catheter into the closed space. Swine were killed at the 3 different time points and liver tissue harvested. Plasmid DNA expression and functional translated protein expression were assessed. RESULTS: ERCP-guided hydrodynamic delivery of naked plasmid DNA facilitated by pCytomegalovirus-Sleep Beauty (pCMV-SB) transposons was technically feasible and devoid of cardiovascular and local adverse events in all 12 pigs. Furthermore, plasmid DNA (both single and combination) was successfully transferred into swine hepatocytes in all 12 pigs. Additionally, stable integration of the DNA constructs in hepatocyte genomic DNA was reliably noted at all 3 time points. In the 4 swine that were kept alive to 60 days, successful genomic integration and subsequent protein expression was observed in the targeted liver tissue. CONCLUSIONS: ERCP-guided hydrodynamic delivery of gene therapy may usher in the next chapter in gene therapy with the potential to impact a variety of single-gene, complex genetic, and epigenetic liver diseases. It also raises the possibility that other nucleic acid therapeutics (microRNA, lncRNA, siRNA, shRNA) could similarly be delivered.
Authors: Christopher J Atkinson; Christopher J Lisanti; Ryan B Schwope; Daniel Ramsey; Timothy Dinh; Allyson Cochet; Michael J Reiter Journal: Abdom Radiol (NY) Date: 2017-05
Authors: Olivia C Hibbitt; Richard P Harbottle; Simon N Waddington; Christine A Bursill; Charles Coutelle; Keith M Channon; Richard Wade-Martins Journal: J Gene Med Date: 2007-06 Impact factor: 4.565
Authors: Constanza Savid-Frontera; Maria E Viano; Natalia S Baez; Della Reynolds; Mariana Matellon; Howard A Young; Maria C Rodriguez-Galan Journal: Immunotherapy Date: 2021-11-16 Impact factor: 4.196
Authors: Yuting Huang; Robert L Kruse; Hui Ding; Mohamad I Itani; Jonathan Morrison; Zack Z Wang; Florin M Selaru; Vivek Kumbhari Journal: PLoS One Date: 2021-04-28 Impact factor: 3.240
Authors: Tatjana Chan; Hiu Man Grisch-Chan; Philipp Schmierer; Ulrike Subotic; Nicole Rimann; Tanja Scherer; Udo Hetzel; Matthias Bozza; Richard Harbottle; James A Williams; Barbara Steblaj; Simone K Ringer; Johannes Häberle; Xaver Sidler; Beat Thöny Journal: Mol Ther Methods Clin Dev Date: 2022-01-19 Impact factor: 6.698
Authors: Robert L Kruse; Yuting Huang; Thomas Shum; Lu Bai; Hui Ding; Zack Z Wang; Florin M Selaru; Vivek Kumbhari Journal: Gastrointest Endosc Date: 2021-06-29 Impact factor: 9.427
Authors: Ling Li; Mohamad I Itani; Kevan J Salimian; Yue Li; Olaya Brewer Gutierrez; Haijie Hu; George Fayad; Jean A Donet; Min Kyung Joo; Laura M Ensign; Vivek Kumbhari; Florin M Selaru Journal: Sci Rep Date: 2021-06-25 Impact factor: 4.379